REFERENCES
- Dehne M G, Boldt J, Heise D, et al. Tamm-Horsfall protein, alpha-1- and beta-2-microglobulin as kidney function markers in heart surgery. Anaesthesist 1995; 44: 545–551
- Sakakibara Y, Fukuda I, Koishizawa T, et al. Early detection and differential diagnosis of renal insufficiency following cardiac surgery–diagnostic value of free water clearance and fractional excretion of sodium. Nippon Kyobu Geka Gakkai Zasshi 1984; 32: 2060–2066
- Corwin H L, Sprague S M, Delaria G A, et al. Acute renal failure associated with cardiac operations. A case-control study. J Thorac Cardiovasc Surg 1989; 98: 1107–1112
- Fitton A, Benfield P. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency [published erratum appears in Drugs 1990 Aug;40(2):following Table of Contents]. Drugs 1990; 39: 308–330
- Jamison M, Widerhorn J, Weber L, et al. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure. Am Heart J 1989; 117: 607–614
- Garre D N Gomez, Farre A Lopez, Eleno N, et al. Comparative effects of dopexamine and dopamine on glycerol-induced acute renal failure in rats. Ren Fail 1996; 18: 59–68
- Scherberich J E. Aminopeptidase A (Angiotensinase A). Urinary Enzymes in Clinincal and Experimental Medicine, K Jung, H Mattenheimer, U Burchardt. Springer, Berlin 1992; 116–124
- McAuley F T, Simpson J G, Thomson A W, et al. The predictive value of enzymuria in cyclosporin A-induced renal toxicity in the rat. Toxicol Lett 1986; 32: 163–169
- Simane Z J. N-Acetyl-b-D-Glucosaminidase. Urinary Enzymes in Clinical and Experimental Medicine, K Jung, H Mattenheimer, U Burchardt. Springer, Berlin 1992; 118–124
- Itoh Y, Enomoto H, Takagi K, et al. Clinical usefulness of serum alpha 1-microglobulin as a sensitive indicator for renal insufficiency [letter]. Nephron 1983; 33: 69–70
- Kumar S, Muchmore A. Tamm-Horsfall protein-uromodulin (1950–1990). Kid Int 1990; 37: 1395–1401
- Dati F, Lammers M. Immunochemical Methods for Determination of Urinary Proteins in Kidney Disease. JFCC 1989; 1: 68–77
- Sharif M N, Kaushal R D, Iyer P, et al. Diltiazem potentiates angiotensin II-mediated renal prostacyclin synthesis. J Cardiovasc Pharmacol 1992; 20: 638–642
- Llopart T, Lombardi R, Forselledo M, Andrade R. Acute renal failure in open heart surgery. Ren Fail 1997; 19(2)319–323
- Sural S, Sharma R K, Singhal M, et al. Etilolgy, prognosis, and outcome of post-operative acute renal failure. Ren Fail 2000; 1: 87–97
- Itoh Y, Kawai T. Human alpha 1-microglobulin: its measurement and clinical significance. J Clin Lab Anal 1990; 4: 376–384
- Donadio C, Puccini R, Lucchesi A, et al. Urinary excretion of proteins and tubular enzymes in renal transplant patients. Ren Fail 1998; 20: 707–715
- Wedeen R P, Udasin I, Fiedler N, et al. Urinary biomarkers as indicators of renal disease. Ren Fail 1999; 21: 241–249
- Kumle B, Boldt J, Piper S, et al. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 1999; 89: 1124–1130
- Viberti G. Prognostic significance of microalbuminuria. Am J Hypertens 1994; 7: 69S–72S
- Chintala M S, Lokhandwala M F, Jandhyala B S. Protective effects of dopexamine hydrochloride in renal failure after acute haemorrhage in anaesthetized dogs. J Auton Pharmacol 1990; 10(Suppl 1)95–102
- Smith G W, O'Connor S E. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride). Am J Cardiol 1988; 62: 9C–17C
- Brown R A, Dixon J, Farmer J B, et al. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors. Br J Pharmacol 1985; 85: 599–608
- Olsen N V, Lund J, Jensen P F, et al. Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993; 79: 685–694
- Olsen N V, Hansen J M, Ladefoged S D, et al. Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. Clin Sci Colch 1990; 78: 503–507
- MacGregor D A, Prielipp R C, Butterworth J F, et al. Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes. Chest 1996; 109: 194–200
- van der Starre P J, Rosseel P M. Dopexamine hydrochloride after coronary artery bypass grafting. Am J Cardiol 1988; 62: 78C–82C
- Jamison M, Widerhorn J, Weber L, et al. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure. Am Heart J 1989; 117: 607–614